MENU
+Compare
KRYS
Stock ticker: NASDAQ
AS OF
Apr 17, 04:59 PM (EDT)
Price
$168.26
Change
+$3.56 (+2.16%)
Capitalization
4.87B

KRYS Krystal Biotech Forecast, Technical & Fundamental Analysis

Krystal Biotech Inc is engaged in the healthcare sector in the United States... Show more

KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KRYS with price predictions
Apr 16, 2025

Aroon Indicator for KRYS shows an upward move is likely

KRYS's Aroon Indicator triggered a bullish signal on April 03, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 199 similar instances where the Aroon Indicator showed a similar pattern. In of the 199 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KRYS's RSI Oscillator exited the oversold zone, of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where KRYS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KRYS advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .

KRYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on KRYS as a result. In of 109 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KRYS turned negative on March 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at .

KRYS moved below its 50-day moving average on April 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KRYS crossed bearishly below the 50-day moving average on April 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRYS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KRYS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.147) is normal, around the industry mean (13.668). P/E Ratio (56.190) is within average values for comparable stocks, (63.094). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.756). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (17.271) is also within normal values, averaging (249.208).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KRYS is expected to report earnings to fall 3.95% to $1.46 per share on May 12

Krystal Biotech KRYS Stock Earnings Reports
Q1'25
Est.
$1.46
Q4'24
Beat
by $0.31
Q3'24
Missed
by $0.08
Q2'24
Missed
by $0.25
Q1'24
Missed
by $0.28
The last earnings report on February 19 showed earnings per share of $1.52, beating the estimate of $1.21. With 303.76K shares outstanding, the current market capitalization sits at 4.87B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company which provides therapies for rare and orphan diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2100 Wharton Street
Phone
+1 412 586-5830
Employees
229
Web
https://www.krystalbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TMDV44.30N/A
N/A
ProShares Russell US Dividend Grwr ETF
FEDM50.35N/A
N/A
FlexShares ESG&Clmt Dev Mkts ex-US Cr
ISD12.95N/A
N/A
PGIM High Yield
DEUS50.94-0.61
-1.17%
Xtrackers Russell US Multifactor ETF
FTLS61.74-1.04
-1.66%
First Trust Long/Short Equity ETF

KRYS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with ACLX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-2.62%
ACLX - KRYS
55%
Loosely correlated
-1.20%
IDYA - KRYS
53%
Loosely correlated
-4.71%
CRNX - KRYS
50%
Loosely correlated
-0.27%
PRME - KRYS
49%
Loosely correlated
-6.06%
ROIV - KRYS
48%
Loosely correlated
-0.40%
More